openPR Logo
Press release

Oncolytic Virus Therapy Market Size, Industry Trends, Share and Forecast 2018-2023

12-31-2020 11:16 AM CET | Health & Medicine

Press release from: Orion Market Research

Oncolytic Virus Therapy Market Size, Industry Trends, Share

Oncolytic virus therapy is based on the treatment through a virus that infects and kills cancer cells. These oncolytic viruses not only destroy the cancerous cell, also prevents the growth of tumour cells by stimulating the host anti-tumour immune responses. The first oncolytic virus therapy was approved in 2015, it is still is in the nascent stage of being considered as suitable and effective cancer therapy. The first oncolytic virus was the genetically modified herpes simplex virus type I that is Talimogene laherparepvec (T-VEC) that reported to be clinically beneficial for patients with melanoma.

Request a Free Sample of our Oncolytic Virus Therapy Market: https://www.omrglobal.com/request-sample/oncolytic-virus-therapy-market

Oncolytic virus therapy market is anticipated to grow at a decent growth rate during the forecast period. Most of the oncolytic virus therapy in clinical trials are in preclinical phase followed by Phase-I trials. At present, two three oncolytic drugs have been commercialised, however, approximately 48 oncolytic virus therapies are in clinical trials. The factors that are fuelling the growth of the market includes higher incidence and prevalence rate of cancer. Melanoma is one of the cancers that has been prevalent across the US region. The first oncolytic virus success over chemotherapy and radiotherapy have paved ways for developing them for other cancers. The other factors are the side effects associated with conventional cancer therapies. Chemotherapy and radiation therapy cause certain side-effects such as prolonged exposure to radiation may cause skin cancer.

A full Report of Oncolytic Virus Therapy Market is Available at: https://www.omrglobal.com/industry-reports/oncolytic-virus-therapy-market

Global oncolytic virus therapy market is segregated on the basis of the geographical regions that are contributing significantly towards the growth of the market. On the basis of the geography, market is segmented into North America, Europe, Asia Pacific and Rest of the World. North America is the dominant market in the oncolytic virus immunotherapy market, globally. R&D in oncolytic virus therapy and cohesive government policies will boost innovative cancer therapies. Europe followed by APAC region are considered to be lucrative regions for the growth of oncolytic virus market owing to larger patient base and adoption for novel immunotherapies.

Oncolytic Virus Therapy Market Segmentation

By Product

• HSV-Based Oncolytic Viruses
• Adenoviruses-Based Oncolytic Viruses
• Vaccinia Virus-Based Oncolytic Viruses
• Vesicular Stomatitis Virus-Based Oncolytic Viruses
• Newcastle Disease Virus-Based Oncolytic Viruses

By Application

• Prostate Cancer
• Breast Cancer
• Ovarian Cancer
• Others
Competitive Landscape

Regional Analysis

• North American
• United States
• Canada
• Europe
• UK
• Germany
• Italy
• Spain
• France
• ROE
• Asia Pacific
• India
• China
• Japan
• ROAPAC
• Rest of the World

Company Profiles

• Amgen
• BioVex Inc.,
• Cold Genesys, Inc.
• Crusade Laboratories
• Cynvec LLC
• Genelux Corp.
• JennerRex Co. Ltd
• Lokon Pharma AB
• MediGene AG
• Merck
• Neotropix, Inc.
• Oncolys BioPharma
• Oncolytics Biotech, Inc.
• Onyx
• Otsuka Pharmaceuticals Co. Ltd
• PsiOxus Therapeutics Ltd
• Roche
• Shanghai Sunway Biotech Co. Ltd
• Silajen Biotherapeutics, Inc.
• Sorrento Therapeutics
• SunWay Biotech Co. Ltd
• Takara Bio, Inc.
• Targovax
• Theravir
• TILT Biotherapeutics
• Transgene SA
• VCN Biosciences SL
• Viralytics Ltd
• Vyriad

For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/oncolytic-virus-therapy-market

Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404

About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Oncolytic Virus Therapy Market Size, Industry Trends, Share and Forecast 2018-2023 here

News-ID: 2219552 • Views:

More Releases from Orion Market Research

Road Marking Paint Market : A Guide to Understanding the Process
Road Marking Paint Market : A Guide to Understanding the Process
The Road Marking Paint Market, valued at approximately USD 5.02 billion in 2023, is projected to reach around USD 7.69 billion by 2033, growing at a compound annual growth rate (CAGR) of 4.36% from 2024 to 2033. Road Marking Paint Market Overview The Road Marking Paint Market is steadily expanding, driven by burgeoning infrastructure investments and the need for improved road safety. Governments and municipalities are increasingly allocating funds toward both new
Outboard Boat Market Size Analysis, Competitive Insights, Leading Players and Growth Opportunities by 2033
Outboard Boat Market Size Analysis, Competitive Insights, Leading Players and Gr …
The Outboard Boats Market, valued at approximately USD 5.74 billion in 2023, is projected to grow to around USD 14 billion by 2033, reflecting a compound annual growth rate (CAGR) of about 9% over the 2024-2033 period. Outboard Boat Market Overview The Outboard Boat Market continues to expand robustly, fueled largely by rising demand for recreational boating, favorable economic conditions, and the appeal of leisure marine activities. Innovations in outboard motor technology-including
Mobile Ticketing Market Size Analysis, Competitive Insights, Leading Players and Growth Opportunities by 2033
Mobile Ticketing Market Size Analysis, Competitive Insights, Leading Players and …
The Mobile Ticketing Market, valued at about USD 2.9 billion in 2023, is anticipated to grow to approximately USD 11.39 billion by 2033, reflecting a robust CAGR of 16.7% from 2024 to 2033. Mobile Ticketing Market Overview The Mobile Ticketing Market is undergoing rapid expansion, driven primarily by the global surge in smartphone usage and consumer preference for contactless, digital experiences. This growth is further propelled by widespread adoption of digital payments,
Metal Alloy Market Size Analysis, Competitive Insights, Leading Players and Growth Opportunities by 2033
Metal Alloy Market Size Analysis, Competitive Insights, Leading Players and Grow …
The Metal Alloy Market, valued at approximately USD 301.7 billion in 2023, is projected to reach USD 533.9 billion by 2033, growing at a compound annual growth rate (CAGR) of 5.9% from 2024 to 2033. Metal Alloy Market Overview The Metal Alloy Market is experiencing steady, long-term expansion, driven by growing demand from key sectors such as automotive, aerospace, construction, and electronics. Applications in next-generation vehicles and aircraft are pushing interest in

All 5 Releases


More Releases for Oncolytic

Prominent Oncolytic Virus Therapy Market Trend for 2025: Accelerating Oncolytic …
Which drivers are expected to have the greatest impact on the over the oncolytic virus therapy market's growth? The rise in cancer incidences is likely to fuel the expansion of the oncolytic virus therapy market. Oncolytic virus therapy is gaining traction as an appealing approach to treating cancer- a collection of diseases marked by abnormal cell growth and proliferation. This therapeutic strategy effectively targets and eliminates cancer cells, while also triggering
Enhancing the Immune Response with Oncolytic Virus Therapy
Oncolytic virus therapy is revolutionizing cancer treatment by harnessing the unique characteristics of viruses to specifically target and destroy cancer cells. This cutting-edge approach represents a significant advancement in cancer care, offering renewed hope for patients with different types of cancer. Download Report: https://www.kuickresearch.com/report-oncolytic-virus-immunotherapy-market-oncolytic-virus-therapy-market-oncolytic-virus-fda-approved-oncolytic-virus-clinical-trilas The essence of oncolytic virus therapy is based on genetically modified viruses that can selectively attack and kill cancer cells while leaving healthy tissue unharmed. These engineered viruses take
Creative Biolabs Unleashes Solutions to Validate Oncolytic Virotherapy
Creative Biolabs introduces safety and efficacy validation strategies for oncolytic virotherapy. New York, USA - June 17, 2024 - Oncolytic virotherapy appears as a new paradigm in cancer immunotherapy that enrolls specifically engineered viruses to selectively infect and kill cancer cells, some of which have marched into clinical trials, like adenoviruses, HSV, reovirus, vaccinia virus, and measles. With so many other candidates still on their preclinical journey, the requests to validate
Oncolytic Virus Competitive Landscape 2023 (Updated)
DelveInsight's, "Oncolytic Virus Competitive Landscape 2023" report provides comprehensive insights about 150+ Oncolytic Virus Companies and 175+ drugs in the Oncolytic Virus Competitive landscape. It covers the Oncolytic Virus therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Key Takeaways from the Oncolytic Virus Competitive Landscape Report • DelveInsight's Oncolytic Virus report depicts a robust space with 150+ Oncolytic
Oncolytic Virus Therapy Market Oncolytic Virus Therapy Clinical Pipeline Report …
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents Prologue to Oncolytic Virus 1.1 Outline of Oncolytic Virotherapy 1.2 Trail from Genesis to Biogenetics Primer of Virotherapy in Malignancies 2.1 Oncolytic Viruses towards Cancer 2.2 Approaches for Targeting Tumor Cells 2.2.1 Pro Apoptotic Targeting 2.2.2 Translational Targeting 2.2.3 Transcriptional Targeting 2.2.4 Transductional Targeting Mechanism
Global Oncolytic Virus Therapy Report Highlight Market Opportunity & Insight On …
“Global Oncolytic Virus Therapy Market and Pipeline Outlook 2022” report analyzes ongoing clinical and non-clinical trends in the oncolytic virus therapy market. Currently there are 2 oncolytic virus therapies commercially available in the market. This report analyzes the ongoing clinical trial of 48 oncolytic virus therapies in clinical pipeline and gives comprehensive clinical insight on various parameters associated with the development of the oncolytic virus therapies. Most of the oncolytic